文献速递男科与性医学

低强度体外冲击波治疗勃起功能障碍成功的预后指标

Prognostic Indicators for Successful Low-intensity Extracorporeal Shock Wave Therapy Treatment of Erectile Dysfunction.
PubMed 文献 · Urology · 2020-12-26

本研究纳入425例血管性勃起功能障碍患者,采用低强度体外冲击波治疗,以6个月时SHIM评分22-25定义为成功。51.8%患者治疗成功,年龄、糖尿病、高血压、吸烟、肥胖、高脂血症、基线SHIM评分和ED病程均为显著影响因素。30个月随访时76.3%的应答者仍维持满意勃起功能。

要点

  • 低强度体外冲击波治疗血管性ED的6个月成功率为51.8%。
  • 年龄、糖尿病、高血压、吸烟、肥胖、高脂血症、基线SHIM评分和ED病程影响治疗成功。
  • 30个月随访时76.3%的治疗应答者仍维持SHIM 22-25且未使用PDE5抑制剂。

核心结论

  • 低强度体外冲击波治疗血管性ED安全有效,30个月随访时39.5%的患者治疗成功。
  • 推荐对轻至中度ED患者提供低强度体外冲击波治疗,不推荐用于重度ED患者。

研究设计与样本

  • 研究纳入425例血管性ED患者,采用PiezoWave2设备进行低强度体外冲击波治疗。
  • 以治疗6个月后SHIM评分22-25定义为治疗成功,对成功患者随访30个月。

主要发现

  • 总体基线SHIM评分均值为11.8,范围5-20。
  • 治疗6个月后220例(51.8%)患者报告满意性交。
  • 年龄、糖尿病、高血压、吸烟、肥胖、高脂血症、治疗前SHIM评分和ED病程均为影响治疗成功的显著因素。
  • 30个月随访时,168例(76.3%)治疗应答者仍报告满意性交且SHIM评分22-25,未使用PDE5抑制剂。

临床怎么用

  • 低强度体外冲击波治疗应提供给轻至中度ED患者,不应提供给重度ED患者。
  • 治疗前应评估年龄、糖尿病、高血压、吸烟、肥胖、高脂血症、基线SHIM评分和ED病程等预后因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess prognostic factors affecting successful low-intensity extracorporeal shockwave therapy (Li-ESWT) treatment of erectile dysfunction (ED) in patients with vasculogenic ED and to report 30-month follow-up. METHODS: This study was conducted upon 425 patients with vasculogenic ED. Assessment of ED was done using Sexual Health Inventory for Men (SHIM) score. Patients were treated by Li-ESWT using PiezoWave2 (Richard Wolf) device. Successful Li-ESWT was defined as 6-month SHIM score of 22-25. Patients with successful treatment were followed for 30 months. RESULTS: Mean Baseline SHIM scores for the total population studied was 11.8 with a range from 5 to 20. After 6 months from treatment, 220 (51.8%) patients reported satisfactory sexual intercourse. Age, diabetes, hypertension, smoking, obesity, hyperlipidemia, pretreatment SHIM score, and the duration of ED were all found to be significant factors affecting the success of Li-ESWT. At 30-month follow-up, 168 (76.3%) patients from those who responded to Li-ESWT still reported satisfactory sexual intercourse with a SHIM score of 22-25 without using PDE5i. CONCLUSION: Li-ESWT is safe and effective treatment of ED with 30 months success in 39.5% of patients treated. Li-ESWT should be offered to patients with mild-to-moderate ED and not to those with severe ED.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Adeldaeim HM, Abouyoussif T, Gebaly OE, et al. Prognostic Indicators for Successful Low-intensity Extracorporeal Shock Wave Therapy Treatment of Erectile Dysfunction. Urology. 2020. PMID: 33373703. doi:10.1016/j.urology.2020.12.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。